June 24, 2008
FOR IMMEDIATE RELEASECONTACT:
MARK BOGUSKI, MD, PHD, JOINS BIDMC DEPARTMENT OF PATHOLOGY
BOSTON -- Newswise — Mark S. Boguski, MD, PhD, has joined the faculty of Beth Israel Deaconess Medical Center (BIDMC) as Associate Professor of Pathology. Internationally known for his leadership and expertise in bioinformatics and all aspects of genomics, Boguski also serves in the Center for Biomedical Informatics at Harvard Medical School (HMS).
He comes to BIDMC from Novartis Institutes for Biomedical Research where he launched a new division of Genome and Proteome Sciences. "Dr. Boguski is one of the founding fathers of computational biology," says Jeffrey Saffitz, MD, PhD, Chief of Pathology at BIDMC. "He has made seminal contributions and developed innovative technologies that have enabled the human genome project and defined the field of comparative genomics in which profound insights into human disease can be learned by studying far simpler organisms, such as yeast, worms and flies."
Prior to his post at Novartis, Boguski held positions as Senior Vice President of Research and Development at Rosetta Inpharmatics (now a wholly owned subsidiary of Merck & Co.) and was the founding Director of the (Paul) Allen Institute for Brain Science in Seattle, Washington. Between 1989 and 2000, while at the National Center for Biotechnology Information at the National Institutes of Health, Boguski pioneered a number of high-impact information resources that contributed to a sea change in the way biologists and biomedical researchers are able to benefit from the Human Genome Project.
Boguski received both the NIH Director's Award and the Regents Award from the National Library of Medicine, and is the author or coauthor of more than 150 scholarly articles and books. A former editor of Genome Research, he has served on the board of reviewing editors for Science magazine and also as Editor-in-Chief of Genomics. Boguski has served as an organizer of the Cold Spring Harbor Symposium on DNA Mapping, Sequencing & Biology, a member of the scientific advisory board of the Merck Genome Research Institute, a member of the Genetics Advisory Group for the Wellcome Trust and an advisor to the Howard Hughes Medical Institute.
Boguski is a member of the Institute of Medicine of the National Academy of Sciences and is as a fellow of the American College of Medical Informatics. He received MD and PhD degrees from the Medical Scientist Training Program at the Washington University School of Medicine in St. Louis.
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and consistently ranks in the top four in National Institutes of Health funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and is a research partner of the Dana-Farber Harvard Cancer Center BIDMC is the official hospital of the Boston Red Sox. For more information, visit http://www.bidmc.harvard.edu.